Erasca, Inc. faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results